posted on 2025-08-01, 12:35authored byAE Hughes, E De Franco, E Globa, N Zelinska, D Hilgard, P Sifianou, AT Hattersley, SE Flanagan
Heterozygous mutations in GCK result in a persistent, mildly raised glucose from birth, but it is usually diagnosed in adulthood as maturity-onset diabetes of the young (MODY), where hyperglycemia is often an incidental finding. The hyperglycemia of GCK-MODY is benign and does not require treatment, but is important to be aware of, particularly in females where it has implications for managing pregnancy. We present three cases of neonatal hyperglycemia resulting from a heterozygous mutation in GCK, illustrating its clinical presentation and evolution in early life. In summary, as with adults, neonatal hyperglycemia is an incidental finding, does not require treatment and has no adverse consequences for health. Neonates and their parents should be referred for genetic testing to confirm the diagnosis, avoid a label of diabetes and enable pregnancy counselling for females found to be affected. This article is protected by copyright. All rights reserved.
This is the final version. Available on open access from Wiley via the DOI in this record
Data availability statement: The data that supports this work is not freely available due to its identifiable nature, but reasonable requests for additional data can be made to the corresponding author.